Sedative, hypnotic or anxiolytic-induced anxiety disorder

Sedative, hypnotic or anxiolytic-induced anxiety disorder is characterized by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behavior) that develop during or soon after intoxication with or withdrawal from sedatives, hypnotics or anxiolytics. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of intoxication or withdrawal due to sedatives, hypnotics or anxiolytics. The amount and duration of sedative, hypnotic or anxiolytic use must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms persist for a substantial period of time after cessation of the sedative, hypnotic or anxiolytic use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with sedative, hypnotic or anxiolytic use).

ICD-11 diagnostic criteria

• objawy lękowe
• związek czasowy z używaniem leków

How to recognise

In the ICD-11 framework, the core symptoms taken into account when recognising Sedative, hypnotic or anxiolytic-induced anxiety disorder are:

• nasilony niepokój

Frequently asked questions

How is Sedative, hypnotic or anxiolytic-induced anxiety disorder diagnosed according to ICD-11?

According to ICD-11, the diagnostic criteria for Sedative, hypnotic or anxiolytic-induced anxiety disorder (6C44.71) include: objawy lękowe; związek czasowy z używaniem leków.

WHO ICD-11 source

View this entry in the official WHO ICD-11 browser: 6C44.71 – WHO ICD-11

Notes

Proszę zakodować również jednostkę chorobową (schorzenie) będące przyczyną